文献速递儿童神经与发育行为儿童呼吸儿童心血管与肾脏

癫痫合并睡眠呼吸暂停患儿的心脏骤停风险

Risk of Sudden Cardiac Arrest in Children With Epilepsy and Sleep Apnea.
PubMed 文献 · Pediatrics · 2025-01-01

该研究基于TriNetX全球网络,纳入2000年至2025年诊断的18岁以下癫痫患儿,按有无睡眠呼吸暂停倾向评分匹配,随访5年和10年。结果显示癫痫合并睡眠呼吸暂停者心脏骤停发生率最高(50.5/万·年),5年HR 1.99、10年HR 1.74,腺样体扁桃体切除术可能降低风险,长期CPAP治疗与风险升高相关。

要点

  • 癫痫合并睡眠呼吸暂停患儿心脏骤停风险显著高于单纯癫痫或单纯睡眠呼吸暂停。
  • 难治性癫痫与心脏骤停风险升高相关(OR 1.74,95%CI 1.25-2.42)。
  • 腺样体扁桃体切除术与心脏骤停风险降低相关(OR 0.40),长期CPAP与风险升高相关(OR 3.41)。

核心结论

  • 癫痫合并睡眠呼吸暂停患儿心脏骤停和心律失常风险显著增加。
  • 腺样体扁桃体切除术可能降低心脏骤停风险,而长期CPAP使用可能增加该风险。

研究设计与样本

  • 基于TriNetX全球研究网络,纳入2000年1月至2025年3月诊断的18岁以下癫痫患儿。
  • 睡眠呼吸暂停通过ICD-10-CM编码和多导睡眠监测记录识别。
  • 按有无睡眠呼吸暂停进行倾向评分匹配,评估5年和10年随访期间的心脏骤停和心律失常。

主要发现

  • 癫痫合并睡眠呼吸暂停者心脏骤停发生率为50.5/万·年,高于单纯癫痫(20.0/万·年)和单纯睡眠呼吸暂停(9.0/万·年)。
  • 难治性癫痫增加心脏骤停风险(OR 1.74,95%CI 1.25-2.42)。
  • 长期CPAP治疗与心脏骤停风险升高相关(OR 3.41,95%CI 2.27-5.11),腺样体扁桃体切除术与风险降低相关(OR 0.40,95%CI 0.27-0.60)。

关键数值与推荐

  • 心脏骤停发生率:癫痫合并睡眠呼吸暂停50.5/万·年,单纯癫痫20.0/万·年,单纯睡眠呼吸暂停9.0/万·年。
  • 难治性癫痫与心脏骤停风险:OR 1.74(95%CI 1.25-2.42)。
  • 长期CPAP与心脏骤停风险:OR 3.41(95%CI 2.27-5.11);腺样体扁桃体切除术:OR 0.40(95%CI 0.27-0.60)。

临床怎么用

  • 对癫痫合并睡眠呼吸暂停的患儿应关注心脏骤停和心律失常风险。
  • 考虑个体化治疗策略,腺样体扁桃体切除术可能有助于降低心脏骤停风险。
  • 长期CPAP治疗与心脏骤停风险升高相关,需权衡利弊。

局限性

  • 本研究为基于数据库的回顾性分析,可能存在编码偏倚和混杂因素。
  • CPAP与心脏骤停风险的关联可能受适应证混杂影响,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pediatric patients with epilepsy are at risk for sudden cardiac arrest (SCA), and sleep apnea (SA) may exacerbate this risk. This study investigates the incidence and risk of SCA and cardiac dysrhythmia in pediatric patients with epilepsy and SA. METHODS: Using the TriNetX global research network, we identified pediatric patients (aged younger than 18 years) who were diagnosed with epilepsy between January 2000 and March 2025. SA was identified using International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes and polysomnography records. Two cohorts, ie, patients with epilepsy with and without SA, were matched using propensity scores. SCA and cardiac dysrhythmia were assessed over 5- and 10-year follow-up periods. RESULTS: The incidence of SCA was highest in patients with both epilepsy and SA (50.5 per 10 000 person-years) compared with those with epilepsy alone (20.0 per 10 000) or SA alone (9.0 per 10 000). Patients with epilepsy and SA had an increased risk of SCA (5-year hazard ratio [HR]: 1.99; 10-year HR: 1.74; both P < .001) and cardiac dysrhythmia (10-year HR: 2.06; P < .001). Refractory epilepsy increased the risk of SCA (odds ratio [OR]: 1.74; 95% CI: 1.25-2.42). Additionally, long-term continuous positive airway pressure (CPAP) therapy was associated with increased SCA risk (OR: 3.41; 95% CI: 2.27-5.11), whereas adenotonsillectomy reduced it (OR: 0.40; 95% CI: 0.27-0.60). CONCLUSIONS: Pediatric patients with epilepsy and SA are at significantly increased risk for SCA and cardiac dysrhythmia. Adenotonsillectomy may mitigate this risk, whereas long-term CPAP use may increase it. These findings highlight the importance of individualized treatment strategies in pediatric patients with epilepsy and comorbid SA to reduce the risk of SCA.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Wu PM, Chiang CW, Wu YH, et al. Risk of Sudden Cardiac Arrest in Children With Epilepsy and Sleep Apnea. Pediatrics. 2025. PMID: 40825556. doi:10.1542/peds.2024-069635

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。